0001950047-24-003294.txt : 20240501 0001950047-24-003294.hdr.sgml : 20240501 20240501165143 ACCESSION NUMBER: 0001950047-24-003294 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240501 DATE AS OF CHANGE: 20240501 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: GYRE THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001124105 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 562020050 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 000-51173 FILM NUMBER: 24903822 BUSINESS ADDRESS: STREET 1: 12770 HIGH BLUFF DRIVE, SUITE 150 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (619) 949-3681 MAIL ADDRESS: STREET 1: 12770 HIGH BLUFF DRIVE, SUITE 150 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST BIOSCIENCES, INC. DATE OF NAME CHANGE: 20150820 FORMER COMPANY: FORMER CONFORMED NAME: TARGACEPT INC DATE OF NAME CHANGE: 20000919 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: USMAN NASSIM CENTRAL INDEX KEY: 0001206872 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 144 144 1 primary_doc.xml 144 0001206872 XXXXXXXX LIVE 0001124105 GYRE THERAPEUTICS, INC. 000-51173 12770 High Bluff Drive Suite 150 San Diego CA 92130 (619) 949-3681 NASSIM USMAN Director Common Morgan Stanley Smith Barney LLC Executive Financial Services

1 New York Plaza 8th Floor New York NY 10004

20000 282472.00 85423246 05/01/2024 NASDAQ Common 05/01/2024 Stock Option Exercise Issuer N 20000 05/01/2024 Cash N NASSIM USMAN

12770 High Bluff Drive Suite 150 San Diego CA 92130

Common 04/01/2024 20000 323056.00 NASSIM USMAN

12770 High Bluff Drive Suite 150 San Diego CA 92130

Common 03/15/2024 20000 345148.00 05/01/2024 12/12/2023 /s/ Nassim Usman